Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US clears Exactech's shoulder pre-formed antibiotic bone cement spacer:

This article was originally published in Clinica

Executive Summary

Exactech has gained FDA go-ahead to market what it claims is the only pre-formed bone cement shoulder spacer that contains an antibiotic available in the US. Its InterSpace shoulder is similar to its other InterSpace products for hips and knees - which were introduced in 2004 - in that it provides consistent and uniform antibiotic release into the local infected area. As with the previous products, it also confers mechanical advantages by maintaining the joint space, and offers patients mobility during the interval of spacer management and the opportunity for improved function following the definitive second-stage operation, said the Gainesville, Florida firm. InterSpace is manufactured by Tecres, of Verona, Italy, and distributed in the US exclusively by Exactech.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT052292

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel